| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
26,423 |
21,358 |
$3.07M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
16,321 |
13,376 |
$1.68M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
10,493 |
8,200 |
$1.12M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,239 |
2,492 |
$737K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
9,522 |
7,856 |
$178K |
| 0002A |
|
1,849 |
1,706 |
$157K |
| 0001A |
|
1,758 |
1,550 |
$135K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
525 |
364 |
$84K |
| 80053 |
Comprehensive metabolic panel |
4,556 |
3,469 |
$70K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,717 |
1,602 |
$68K |
| 70450 |
Computed tomography, head or brain; without contrast material |
298 |
245 |
$53K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
472 |
443 |
$46K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
473 |
435 |
$45K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,434 |
1,053 |
$43K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
25,735 |
20,194 |
$35K |
| 87536 |
|
456 |
424 |
$31K |
| 0004A |
|
436 |
389 |
$31K |
| 80320 |
|
211 |
169 |
$19K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
2,184 |
1,400 |
$16K |
| 0071A |
|
213 |
171 |
$14K |
| 0064A |
|
184 |
182 |
$14K |
| 36415 |
Collection of venous blood by venipuncture |
5,441 |
3,997 |
$14K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,687 |
1,572 |
$14K |
| 80047 |
|
3,884 |
2,799 |
$12K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
177 |
161 |
$11K |
| 0031A |
|
125 |
116 |
$10K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
6,653 |
5,329 |
$10K |
| 0072A |
|
140 |
128 |
$10K |
| 80364 |
|
86 |
72 |
$8K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
150 |
113 |
$7K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
31 |
26 |
$7K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
286 |
149 |
$7K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
252 |
83 |
$6K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
33 |
24 |
$6K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
135 |
126 |
$5K |
| 0012A |
|
59 |
54 |
$5K |
| 80076 |
|
365 |
328 |
$5K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
286 |
149 |
$5K |
| 84484 |
|
805 |
517 |
$5K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
215 |
74 |
$5K |
| 86703 |
|
113 |
112 |
$4K |
| 0054A |
|
127 |
123 |
$4K |
| 86780 |
|
96 |
96 |
$4K |
| 0011A |
|
43 |
39 |
$4K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,754 |
1,288 |
$4K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
110 |
89 |
$4K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
65 |
58 |
$3K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
77 |
66 |
$3K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
88 |
85 |
$3K |
| 97602 |
|
44 |
24 |
$2K |
| 71045 |
Radiologic examination, chest; single view |
732 |
515 |
$2K |
| 0003A |
|
18 |
17 |
$2K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
25 |
16 |
$1K |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
51 |
51 |
$1K |
| 84443 |
Thyroid stimulating hormone (TSH) |
142 |
136 |
$1K |
| 86360 |
|
31 |
29 |
$1K |
| 86803 |
|
38 |
38 |
$1K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
22 |
22 |
$1K |
| 86359 |
|
43 |
41 |
$973.54 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,177 |
848 |
$966.00 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
12 |
12 |
$507.43 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
13 |
13 |
$365.60 |
| 84703 |
|
793 |
574 |
$193.55 |
| 84439 |
|
14 |
14 |
$183.68 |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
138 |
52 |
$152.52 |
| 83690 |
|
934 |
766 |
$136.84 |
| 85014 |
|
2,185 |
1,480 |
$108.06 |
| 81001 |
|
112 |
105 |
$95.01 |
| 82248 |
|
1,285 |
986 |
$75.38 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
549 |
400 |
$4.80 |
| 85610 |
|
91 |
76 |
$3.97 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,201 |
950 |
$2.14 |
| 99253 |
|
12 |
12 |
$0.00 |
| 85730 |
|
74 |
63 |
$0.00 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
48 |
46 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
15 |
12 |
$0.00 |
| 83735 |
|
35 |
30 |
$0.00 |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
110 |
32 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
28 |
27 |
$0.00 |
| 85027 |
|
64 |
36 |
$0.00 |
| 71046 |
Radiologic examination, chest; 2 views |
212 |
198 |
$0.00 |
| 80305 |
|
101 |
78 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
264 |
209 |
$0.00 |
| 81003 |
|
13 |
13 |
$0.00 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
12 |
12 |
$0.00 |
| 80306 |
|
15 |
12 |
$0.00 |